Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells

被引:0
|
作者
Lovorka Stojic
Zuzana Jasencakova
Carolina Prezioso
Alexandra Stützer
Beatrice Bodega
Diego Pasini
Rebecca Klingberg
Chiara Mozzetta
Raphael Margueron
Pier Lorenzo Puri
Dirk Schwarzer
Kristian Helin
Wolfgang Fischle
Valerio Orlando
机构
[1] Dulbecco Telethon Institute,Department of Oncology
[2] IRCCS Fondazione Santa Lucia,Biotech Research and Innovation Centre (BRIC)
[3] University of Cambridge,Laboratory of Chromatin Biochemistry
[4] Cancer Research UK Cambridge Research Institute,Department of Biology and Genetics for Medical Sciences
[5] University of Copenhagen,Department of Experimental Oncology
[6] Max Planck Institute for Biophysical Chemistry,Department of Chemical Biology/Protein Chemistry
[7] University of Milan,undefined
[8] European Institute of Oncology,undefined
[9] c/o IFOM-IEO Campus,undefined
[10] Leibniz-Institut fuer Molekulare Pharmakologie (FMP),undefined
[11] Universitè Paris Diderot Paris 7,undefined
[12] CNRS,undefined
[13] Curie Institute,undefined
[14] Unité de Génétique et Biologie du Développement,undefined
[15] The Sanford Burnham Institute,undefined
来源
关键词
C2C12 Cell; Myogenic Differentiation; Skeletal Muscle Differentiation; Chick Embryo Extract; Human Primary Myoblast;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Keeping the gate closed: functions of the polycomb repressive complex PRC2 in development
    Mozgova, Iva
    Koehler, Claudia
    Hennig, Lars
    PLANT JOURNAL, 2015, 83 (01): : 121 - 132
  • [42] Epigenetic Regulation of the Class II Transactivator (CIITA) by the Polycomb Repressive Complex 2 (PRC2)
    Boyd, Nathaniel
    Greer, Susanna
    FASEB JOURNAL, 2012, 26
  • [43] In aggressive variants of non-Hodgkin lymphomas, Ezh2 is strongly expressed and polycomb repressive complex PRC1.4 dominates over PRC1.2
    Abd Al Kader, Lamia
    Oka, Takashi
    Takata, Katsuyoshi
    Sun, Xu
    Sato, Hiaki
    Murakami, Ichiro
    Toji, Tomohiro
    Manabe, Akihiro
    Kimura, Hiroshi
    Yoshino, Tadashi
    VIRCHOWS ARCHIV, 2013, 463 (05) : 697 - 711
  • [44] Cytosolic EZH1 muscles PRC2 out of the nucleus
    Zlotorynski, Eytan
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2017, 18 (05) : 276 - 276
  • [45] Cytosolic EZH1 muscles PRC2 out of the nucleus
    Eytan Zlotorynski
    Nature Reviews Molecular Cell Biology, 2017, 18 : 276 - 277
  • [46] In aggressive variants of non-Hodgkin lymphomas, Ezh2 is strongly expressed and polycomb repressive complex PRC1.4 dominates over PRC1.2
    Lamia Abd Al Kader
    Takashi Oka
    Katsuyoshi Takata
    Xu Sun
    Hiaki Sato
    Ichiro Murakami
    Tomohiro Toji
    Akihiro Manabe
    Hiroshi Kimura
    Tadashi Yoshino
    Virchows Archiv, 2013, 463 : 697 - 711
  • [47] Long Residence Time Inhibition of EZH2 in Activated Polycomb Repressive Complex 2
    Van Aller, Glenn S.
    Pappalardi, Melissa Baker
    Ott, Heidi M.
    Diaz, Elsie
    Brandt, Martin
    Schwartz, Benjamin J.
    Miller, William H.
    Dhanak, Dashyant
    McCabe, Michael T.
    Verma, Sharad K.
    Creasy, Caretha L.
    Tummino, Peter J.
    Kruger, Ryan G.
    ACS CHEMICAL BIOLOGY, 2014, 9 (03) : 622 - 629
  • [48] VLDL induces EZH2/PRC2 complex-mediated cellular senescence in metabolic syndrome to enhance cardiotoxicity
    Lin, Y. H.
    Lee, H. C.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [49] EZH1 in germ cells safeguards the function of PRC2 during spermatogenesis
    Mu, Weipeng
    Starmer, Joshua
    Shibata, Yoichiro
    Yee, Della
    Magnuson, Terry
    DEVELOPMENTAL BIOLOGY, 2017, 424 (02) : 198 - 207
  • [50] Lineage-specific PRC2 targets and response to EZH2 inhibition in neuroendocrine prostate cancer
    Venkadakrishnan, Varadha Balaji
    Singh, Richa
    Yamada, Yasutaka
    Mizuno, Kei
    Presser, Adam G.
    Ku, Sheng-Yu
    Long, Henry
    Rickman, David
    Beltran, Himisha
    CANCER RESEARCH, 2023, 83 (11)